LensGen
Latest round
- Series A
Last raised
- May 2017
Total raised
- $23M
Investors
- 3
About LensGen
LensGen, Inc.Founded in 2012 and headquartered in Irvine, US, LensGen, Inc. specializes in ophthalmic medical devices.LensGen specializes in ophthalmic medical devices, particularly its flagship product, the Juvene™ Intraocular Lens, which is an investigational device designed to restore youthful vision by mimicking the natural human lens’s ability to change curvature. This product aims to address significant eye conditions such as presbyopia—the age-related loss of the lens’s ability to focus on near objects—and cataracts, which involve the clouding of the natural lens. By utilizing a proprietary design that works in conjunction with the eye's natural accommodation mechanism, the Juvene lens facilitates a continuous range of vision from distance to near, effectively eliminating the need for reading glasses.LensGen operates on a transactional revenue model primarily through partnerships with healthcare providers and surgical centers that perform cataract surgeries. Revenue is generated from the sale of the Juvene™ Intraocular Lens to these medical facilities, which then utilize the product in surgical procedures performed on patients experiencing presbyopia and cataracts. The company's revenue structure is centered on B2B transactions, where healthcare institutions acquire the lens for use in their practices. While specific pricing plans have not been disclosed, the economic framework suggests that revenue is derived from device sales during surgical interventions, aligning with conventional cataract surgery practices, which number over 28 million procedures annually worldwide.In August 2020, LensGen, Inc. The company is focused on launching additional innovative ophthalmic devices designed to enhance vision correction capabilities. Future plans include targeting expansion into regions with increasing demands for cataract surgeries and innovative eye care solutions, with specific timelines for market entry yet to be announced.
Who invested in LensGen
3 investors across 2 rounds
See all investors in LensGen
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about LensGen
Who invested in LensGen?
LensGen has 3 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has LensGen raised?
LensGen has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did LensGen last raise money?
LensGen's most recent round on record is a Series A, in May 2017.
What does LensGen do?
LensGen is a medical devices & equipment company.
Where is LensGen headquartered?
LensGen is headquartered in Irvine, US.
Which VCs invest in companies like LensGen?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back medical devices & equipment companies at LensGen's stage. Their profiles are linked below.
VCs backing medical devices & equipment startups at Series A
Raising like LensGen? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.